Your shopping cart is currently empty

GSK9311 hydrochloride, a less active analog of GSK6853, can be used as a negative control. GSK9311 hydrochloride inhibits BRPF bromodomain (pIC50s: 6.0 and 4.3 for BRPF1 and BRPF2).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $297 | 35 days | 35 days |
| Description | GSK9311 hydrochloride, a less active analog of GSK6853, can be used as a negative control. GSK9311 hydrochloride inhibits BRPF bromodomain (pIC50s: 6.0 and 4.3 for BRPF1 and BRPF2). |
| Targets&IC50 | BRPF2:4.3(pIC50), BRPF1:6(pIC50) |
| In vitro | GSK6853, an analog less active due to 5-amide alkylation, is a highly potent (300 pM), soluble, and cell-active (20 nM) inhibitor of the BRPF1 bromodomain. Its selectivity and properties make it suitable for cellular and in vivo studies. |
| Molecular Weight | 474 |
| Formula | C24H32ClN5O3 |
| Cas No. | 2253733-09-2 |
| Smiles | N(C(=O)C1=C(OC)C=CC=C1)(CC)C2=C(C=C3C(=C2)N(C)C(=O)N3C)N4[C@H](C)CNCC4.Cl |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.